To assess the long-term follow-up of the globus pallidus internus (GPi) stimulation, six patients were evaluated every year by using the Unified Parkinson's Disease Rating Scale (UPDRS). Three years postoperatively, GPi stimulation led to a significant improvement of dyskinesia severity (50%, P = 0.
Globus pallidus stimulation improves both motor and nonmotor aspects of quality of life in advanced Parkinson's disease
✍ Scribed by Julian P. Rodrigues; Susan E. Walters; Peter Watson; Rick Stell; Frank L. Mastaglia
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 99 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Our purpose was to measure the change in quality of life (QoL) following deep brain stimulation of the globus pallidus interna (GPi‐DBS) in advanced Parkinson 's disease (PD), and identifies any associations with changes in motor features of the disease. Eleven patients (age range 54–69 years, 2 women) underwent GPi‐DBS (4 unilateral, 7 bilateral). Outcome measures included assessment of PD‐specific QoL (mean 8 months postsurgery) using the PDQ‐39 questionnaire, and standard motor assessments. Off‐period UPDRS III motor scores fell by (43 ± 8)% (mean ± SEM). Dyskinesia severity was reduced on the abnormal involuntary movement scale by (80 ± 3)% and UPDRS IVa by (58 ± 8)%. QoL as assessed by the PDQ39SI improved by (30 ± 5)%, with significant improvements in mobility, activities of daily living, bodily discomfort, emotional wellbeing, communication, and cognitions subscales. Bilateral and unilateral groups demonstrated equivalent PDQ39SI improvement. QoL improvement was highly correlated with dyskinesia reduction but not reduction in UPDRS score or age at surgery. GPi‐DBS markedly improves QoL in advanced PD. The impacts are broad and improve QoL domains not directly affected by the motor symptoms of the disease. Reduced dyskinesia plays a major role in the improvement of QoL in GPi‐DBS treated patients. © 2007 Movement Disorder Society
📜 SIMILAR VOLUMES
## Abstract We examined the impact of the subthalamic nuclei (STN) deep brain stimulation (DBS) on the health‐related quality of life (QoL) of patients with advanced Parkinson's disease (PD). Seventeen consecutive patients with refractory motor fluctuations and dyskinesia were included in the study
## Abstract We investigated the impact of subthalamic nucleus (STN) deep brain stimulation (DBS) on quality of life (QOL) in patients with advanced Parkinson's disease, as self‐assessed before and after surgery by completing the Parkinson's Disease Questionnaire (PDQ39). In addition to this prospec
## Abstract Deep brain stimulation (DBS) of the subthalamic nucleus (STN) significantly improves quality of life (QoL) in PD. However, QoL fails to improve in a relevant proportion of patients. We studied clinical baseline and progression parameters associated with improvement in QoL after DBS. Dat
We report the therapeutic effects of deep brain stimulation (DBS) in 2 patients with Parkinson's disease (PD) with severe end of dose dyskinesia that was resistant to medical therapy. In both patients, severe, end of day ballistic dyskinesias occurred when the last levodopa dose of the day was weari
## Abstract The impact of dyskinesias and motor fluctuations on quality of life (QOL) at various stages in the course of Parkinson's disease (PD) is not well understood. In 301 subjects with early PD enrolled in a clinical trial (CALM‐PD), we quantified the impact of motor complications on QOL and